Suffering with itchy eyes, a runny nose or constant sneezing? You’re not alone — pollen season is well underway, making the walks and outdoor gatherings that were formerly the highlights of lockdown living a nuisance. As the country continues to open up, it’s increasingly important to get allergies under control, though experts note it is… Read More »
Bristol-Myers Squibb investors have been dreading the arrival of Merck’s Keytruda in kidney cancer, one of Opdivo’s key growth areas. Bristol’s execs? Not so much. The company has been preparing for the launch of I-O-plus-TKI regimens—such as the marriage of Keytruda and Pfizer’s Inlyta that won FDA approval Monday, or the Bavencio-Inlyta duo that Pfizer… Read More »
It’s no surprise that medical marketing spending has skyrocketed in the past 20 years. And while marketing to physicians continues to consume the lion’s share of the almost $ 30 billion spent overall, direct-to-consumer marketing is catching up. Medical marketers spent $ 29.9 billion to get their messages in front of healthcare providers and consumers… Read More »